Literature DB >> 1060915

Dihydrofolate reductase deficiency causing megaloblastic anemia in two families.

G P Tauro, D M Danks, P B Rowe, M B Van der Weyden, M A Schwarz, V L Collins, B W Neal.   

Abstract

To determine the cause of severe megaloblastosis detected at birth and at four weeks in two unrelated infants their bone marrow and liver cells were studied. Both patients had abnormal deoxyuridine suppression tests, corrected to normal by 5-formyl tetrahydrofolic acid. Liver-cell homogenate from one patient had a previously undetectable level of dihydrofolate reductase restored to normal by high cation concentration in the assay. Activity of the liver-cell homogenate from the other patient, which was one quarter of the normal level, was restored to only half normal activity by high cation concentration. Dihydrofolic acid reductase deficiency prevents this conversion of folic acid to tetrahydrofolic acid; the enzyme activity appears to differ in each patient. A satisfactory clinical response in both patients followed parenteral therapy with 5-formyl tetrahydrofolic acid. One sibling in each family died of a similar illness. Autosomal recessive inheritance is probable.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1060915     DOI: 10.1056/NEJM197602262940903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  9 in total

1.  Hereditary transcobalamin II deficiency: a 22 year follow up.

Authors:  P K Thomas; A V Hoffbrand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

2.  Pathology of folate deficiency.

Authors:  A V Hoffbrand
Journal:  Proc R Soc Med       Date:  1977-02

3.  Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency.

Authors:  Siddharth Banka; Henk J Blom; John Walter; Majid Aziz; Jill Urquhart; Christopher M Clouthier; Gillian I Rice; Arjan P M de Brouwer; Emma Hilton; Grace Vassallo; Andrew Will; Desirée E C Smith; Yvo M Smulders; Ron A Wevers; Robert Steinfeld; Simon Heales; Yanick J Crow; Joelle N Pelletier; Simon Jones; William G Newman
Journal:  Am J Hum Genet       Date:  2011-02-11       Impact factor: 11.025

4.  Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease.

Authors:  Holger Cario; Desirée E C Smith; Henk Blom; Nenad Blau; Harald Bode; Karlheinz Holzmann; Ulrich Pannicke; Karl-Peter Hopfner; Eva-Maria Rump; Zuleya Ayric; Elisabeth Kohne; Klaus-Michael Debatin; Yvo Smulders; Klaus Schwarz
Journal:  Am J Hum Genet       Date:  2011-02-11       Impact factor: 11.025

5.  Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria.

Authors:  D Leclerc; A Wilson; R Dumas; C Gafuik; D Song; D Watkins; H H Heng; J M Rommens; S W Scherer; D S Rosenblatt; R A Gravel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 6.  Drugs and folate metabolism.

Authors:  D G Lambie; R H Johnson
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

7.  Neurological involvement in hereditary transcobalamin II deficiency.

Authors:  P K Thomas; A V Hoffbrand; I S Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-01       Impact factor: 10.154

Review 8.  Genetic patterns of transcobalamin II and the relationships with congenital defects.

Authors:  M Fràter-Schröder
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

9.  Megaloblastic anemia and immune abnormalities in a patient with methionine synthase deficiency.

Authors:  J Zittoun; A Fischer; J Marquet; J L Pérignon; A Lagrue; C Griscelli
Journal:  Acta Paediatr Scand       Date:  1987-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.